Oikawa Takefumi, Ohira Tatsuo, Matsubayashi Jun, Konaka Chimori, Ikeda Norihiko
Division of Thoracic Surgery, Chemotherapy Research Institute, Kaken Hospital, Ichikawa-shi, Japan.
Division of Thoracic Surgery, Tokyo Medical University, Tokyo, Japan.
Clin Lung Cancer. 2015 Sep;16(5):374-8. doi: 10.1016/j.cllc.2015.03.007. Epub 2015 Apr 2.
The pathologic diagnosis has become a greater consideration in decision-making regarding the treatment options for lung cancer. Therefore, the accurate diagnosis of the tumor histologic type is essential, even when only small biopsy or cytology samples are available. However, the risk of a misdiagnosis with smaller biopsy samples is greater. The factors underlying the increased risk of a misdiagnosis in small samples are unknown. The aim of the present study was to identify the clinical and pathologic factors (other than immunohistochemical staining) that influence the pathologic diagnostic accuracy in small biopsy and cytological lung samples obtained by bronchoscopy.
We performed transbronchial lung biopsy or brushing and lavage to determine the preoperative diagnosis of 126 of 299 surgically resected lung cancer specimens. We assessed the diagnostic accuracy of the preoperative transbronchoscopic examination findings against that of the surgically resected lung specimens.
On univariate analysis, the mean pathologic tumor size in the noncorresponding cases was larger than that in corresponding cases. Vascular invasion was also more prevalent in the noncorresponding cases. The tumor differentiation grade in the noncorresponding cases was poorer than in the corresponding cases. The noncorresponding cases were at a more progressed stage. On multivariate analysis, the pathologic tumor size and tumor differentiation grade were associated with the noncorresponding cases.
We found a larger tumor size and poor differentiation grade were indicative of lung cancer tissue with a greater content of heterogeneous cells. Therefore, a possibility exists of a false diagnosis using only these factors. Thus, treatment decisions should be made considering the pathologic diagnosis and other relevant factors.
病理诊断在肺癌治疗方案的决策中愈发重要。因此,即便仅有小活检或细胞学样本,准确诊断肿瘤组织学类型也至关重要。然而,小活检样本误诊的风险更高。小样本中误诊风险增加的潜在因素尚不清楚。本研究的目的是确定影响经支气管镜获取的小活检和细胞学肺样本病理诊断准确性的临床和病理因素(免疫组化染色除外)。
我们对299例手术切除的肺癌标本中的126例进行了经支气管肺活检或刷检及灌洗,以确定术前诊断。我们将术前经支气管镜检查结果的诊断准确性与手术切除的肺标本的诊断准确性进行了评估。
单因素分析显示,不相符病例的平均病理肿瘤大小大于相符病例。不相符病例中血管侵犯也更常见。不相符病例的肿瘤分化程度比相符病例差。不相符病例处于更进展的阶段。多因素分析显示,病理肿瘤大小和肿瘤分化程度与不相符病例相关。
我们发现肿瘤体积较大和分化程度差表明肺癌组织中异质性细胞含量较高。因此,仅依据这些因素存在误诊的可能性。所以,应综合病理诊断及其他相关因素做出治疗决策。